Devex Senior Reporter, Michael Igoe, will sit down for a one-on-one interview with Peter Sands, Executive Director of The Global Fund, for a discussion about the future of global health funding and what that means for achieving UHC. The conversation will dive into the Global Fund’s upcoming replenishment, the outlook on AIDS, tuberculosis and malaria, and how we can achieve health care for all.
Michael Igoe is a Senior Reporter with Devex, based in Washington, D.C. He covers U.S. foreign aid, global health, climate change, and development finance. Prior to joining Devex, Michael researched water management and climate change adaptation in post-Soviet Central Asia, where he also wrote for EurasiaNet. Michael earned his bachelor's degree from Bowdoin College, where he majored in Russian, and his master’s degree from the University of Montana, where he studied international conservation and development.
Ronald T. Piervincenzi, Ph.D., has served as Chief Executive Officer of the United States Pharmacopeia since February 2014. Dr. Piervincenzi provides strategic leadership to USP’s global staff of over 1,200 across 10 global sites. His transformative vision has launched key USP initiatives in bringing quality across the healthcare spectrum, upholding USP’s reputation as a quality leader since its founding in 1820. Under his leadership, USP has modernized its operations and launched innovative new science, including in the areas of digital medicine, cutting-edge manufacturing technologies and advanced biologics.
Peter Sands became the Executive Director of the Global Fund in March 2018. As former Chief Executive Officer of Standard Chartered PLC, one of the world’s leading international banks, Sands has been a research fellow at Harvard University since 2015, dividing his time between the Mossavar-Rahmani Center for Business and Government at Harvard Kennedy School and the Harvard Global Health Institute, working on a range of research projects in financial markets and regulation, fintech and global health.